Australia · Investor

Brandon Capital

Last cheque observed Sep 2026; 32 cheques on record.

Deploying nowNew fund $439M, Jul 2025VC firm

Pre-seedSeedSeries ABiotechnologyLife ScienceMedical

Deploying now
70%of best year7cheques in 12 months, 32 on record
Since the last cheque60days00hrs00min00sec
Median round$19MRounds led1 of 32Sole investor7 roundsMostly inAustralia, 53%
Pitch Brandon Capital

Brandon Capital highlights

  1. 01

    7 cheques in the last 12 months

  2. 02

    Mostly Series B and Venture: 52% of its rounds

  3. 03

    Sole investor in 7 rounds, median $2.1M

What they do

Brandon Capital invests in the most promising biomedical opportunities that have the potential to improve the lives of patients.From their own website
Type
VC firm
Cheque size
Not stated
Stages
Pre-seedSeedSeries ASeries BGrowth
Sectors
BiotechnologyLife ScienceMedical
Based in
Melbourne, Australia
Cold pitches
Not stated

The record

Every round we can evidence, newest first32 appearances

  1. 2026

    5 rounds

  2. Sept
    ENA RespiratoryGrant · AU · Brandon Capital$2.1MWith 3 others
  3. Jul
    AdvanCellSeries D · AU · QRM Capital$315MWith 16 others
  4. Jun
    Entact BioVenture · US$10MWith 2 others
  5. Mar
    LumonusSeries B · AU · Startup Daily$28MWith 3 others
  6. Feb
    OncoRes MedicalGrowth · AU · Firms' own news pages$19MWith 6 others
  7. 2025

    9 rounds

  8. Nov
    LumonusSeries B · AU$18MWith 1 other
  9. Nov
    Respirion PharmaceuticalsGrant · AU$649KSole investor
  10. Oct
    ENA RespiratorySeries B · AU · Startup Daily$22MLed
  11. Sept
    NRG TherapeuticsSeries B · GB · Firms' own news pages$68MWith 6 others
  12. Aug
    VaxxasSeries D · AU · Startup Daily$49MWith 4 others
  13. Aug
    MirugenSeed · AU · Firms' own news pages$2.9MWith 2 others
  14. Jun
    Allay TherapeuticsSeries D · US · Firms' own news pages$58MWith 14 others
  15. May
    PolyActivaSeries C · AU · Startup Daily$26MWith 1 other
  16. Feb
    AdvanCellSeries C · AU · Startup Daily$112MWith 6 others
  17. 2024

    7 rounds

  18. Dec
    OkogenVenture · US$3.3MSole investor
  19. Jul
    CatalYmSeries D · DE$150MWith 3 others
  20. Jul
    Myricx BioSeries A · GB$115MWith 3 others
  21. May
    Currus BiologicsVenture · AUUndisclosedWith 2 others
  22. May
    Pheon TherapeuticsSeries B · GB$120MWith 4 others
  23. Apr
    Pathios TherapeuticsSeries B · GB$25MWith 2 others
  24. Jan
    AravaxSeries B · AU$22MWith 3 others
  25. 2023

    3 rounds

  26. Oct
    AstronauTxSeries A · GB · UCL Technology Fund$61MWith 7 others
  27. May
    Cincera TherapeuticsGrant · AU$327KSole investor
  28. Jan
    Perx HealthVenture · USUndisclosedWith 3 others
  29. 2022

    4 rounds

  30. Sept
    OccuRxSeries B · AU$15MWith 2 others
  31. Jul
    DentericVenture · AUUndisclosedSole investor
  32. Jul
    George MedicinesVenture · GB$1.0MSole investor
  33. Jun
    TamoRxVenture · NZ$9.9MWith 1 other
  34. 2021

    1 round

  35. Jul
    Amaroq TherapeuticsSeed · NZ$9.7MSole investor
  36. 2019

    2 rounds

  37. Dec
    Pathios TherapeuticsSeries A · GB · FinSMEs$8.8MWith 1 other
  38. Sept
    DentericSeries A · AU · Startup Daily$9.4MWith 1 other
  39. 2018

    1 round

  40. Mar
    OkogenSeries A · US · Benzinga$10MSole investor

An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.

The team

We hold 37 people at this firm from the lists this database was built from: a weaker source than the filings, since a list does not say when a title ended. Login to see them.

What they claim to have backed

From their own portfolio page (on their website)

1 of 5 we have independently watched raise

PerxhealthAussie gene therapyAustralian company MirugenPerx Health bagsQBE boosts recovery

Weaker than a round we watched, stronger than a list somebody sold us. A firm is far less willing to put a company on its own site that it never funded.

Who they invest alongside

The investors most often in the same rounds as Brandon Capital. A count of rooms they were both in, not a relationship either has claimed.

Recently backed

The latest companies Brandon Capital put money into.

Quick answers about Brandon Capital

What does Brandon Capital invest in?

Brandon Capital invests most often at Series B and Venture (52% of the rounds on record), in sectors such as Biotechnology, Life Science and Medical.

How active is Brandon Capital?

32 investments on record, 7 of them in the last 12 months, and it led 1. The most recent was in Sept 2026.

What has Brandon Capital invested in recently?

Its most recent investments on record: ENA Respiratory (Grant, Sept 2026), AdvanCell (Series D, Jul 2026) and Entact Bio (Venture, Jun 2026).

How big are Brandon Capital's cheques?

The median round it joins is $19M.

Does Brandon Capital lead rounds?

Sometimes: it led 1 of its 32 investments on record (3%).

Where does Brandon Capital invest?

Most of the companies it backs are in Australia (53%), the United Kingdom (22%) and the United States (16%).

Is Brandon Capital investing now?

Yes: it is actively investing, with 7 investments in the last 12 months.

Who does Brandon Capital invest alongside?

Most often Uniseed Ventures (5 rounds together), iSeed (4 rounds together) and Canaan (3 rounds together).

Raising now?

Find the investors who back rounds like yours, and keep every conversation on one fundraising board.

Built from the rounds we watched, its filings and its own website, refreshed every night. How we count · Report a correction · Is this your firm? Claim it